Plunkett Research Online: AdvanSource Biomaterials Corporation

ADVANSOURCE BIOMATERIALS CORPORATION (ASNB:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AdvanSource Biomaterials Corporation develops advanced polymer materials used in the design and development of medical devices for a range of anatomical site and disease state treatment. The firm provides products with both short- and long-term implant applications, including stents, artificial hea.....



AdvanSource Biomaterials Corporation
Ticker: ASNB
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 978 657-0075
Fax:
Address: 229 Andover Street
Wilmington, MA 01887 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Polymer Material Manufacturing
Medical Device Design
Polyurethane-Based Biomaterials
ContactsDescription
Michael AdamsCEO/President/Director
David VolpeCFO
See More
AdvanSource Biomaterials Corporation develops advanced polymer materials used in the design and development of medical devices for a range of anatomical site and disease state treatment. The firm provides products with both short- and long-term implant applications, including stents, artificial hea.....See More See More

Auditor: RBSM LLP
Legal Advisor: Seyfarth Shaw LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
ChronoFlex
ChronoThane
ChronoPrene
ChronoSil
HydroThane
HydroMed
PolyBlend
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: